Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis
Vina P. Nguyen(Boston University), Vaishali Sanchorawala(Boston Medical Center), Michelle Kaku(Icahn School of Medicine at Mount Sinai), Anthony C Shelton, Shayna Sarosiek(Harvard University), Dina Brauneis(Boston University), J. Mark Sloan(Boston University), Karen Quillen(Boston University)
Cited by 5
Related Papers
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615
Systemic immunoglobulin light chain amyloidosis
|Nature Reviews Disease Primers|2018|550
Development and validation of an interpretable deep learning framework for Alzheimer’s disease classification
|Brain|2020|487
Multimodal deep learning for Alzheimer’s disease dementia assessment
|Nature Communications|2022|390